SFRS5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.157200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.660000E-01
Normal-vs-Stage2
4.060600E-01
Normal-vs-Stage3
3.181600E-01
Normal-vs-Stage4
4.985200E-01
Stage1-vs-Stage2
4.897600E-01
Stage1-vs-Stage3
2.183600E-01
Stage1-vs-Stage4
7.951200E-01
Stage2-vs-Stage3
2.025800E-01
Stage2-vs-Stage4
3.320800E-01
Stage3-vs-Stage4
4.385700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.258600E-01
Normal-vs-AfricanAmerican
3.064000E-01
Normal-vs-Asian
3.661200E-01
Caucasian-vs-AfricanAmerican
6.396300E-02
Caucasian-vs-Asian
2.513200E-01
AfricanAmerican-vs-Asian
2.821800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.095200E-01
Normal-vs-Female
4.262800E-01
Male-vs-Female
5.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.861800E-01
Normal-vs-Age(41-60Yrs)
4.408000E-01
Normal-vs-Age(61-80Yrs)
4.031600E-01
Normal-vs-Age(81-100Yrs)
4.009600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.227000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.954020E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.741170E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.868960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.899000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.477800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.986400E-01
Normal-vs-Daily Drinker
4.416400E-01
Normal-vs-Weekly Drinker
3.600800E-01
Normal-vs-Occasional Drinker
5.081000E-01
Normal-vs-Social Drinker
4.076800E-01
Non Drinker-vs-Daily Drinker
3.778000E-01
Non Drinker-vs-Weekly Drinker
4.112600E-01
Non Drinker-vs-Occasional Drinker
1.605420E-01
Non Drinker-vs-Social Drinker
8.706800E-01
Daily Drinker-vs-Weekly Drinker
1.401030E-01
Daily Drinker-vs-Occasional Drinker
4.167200E-01
Daily Drinker-vs-Social Drinker
5.455200E-01
Weekly Drinker-vs-Occasional Drinker
7.987800E-02
Weekly Drinker-vs-Social Drinker
3.792000E-01
Occasional Drinker-vs-Social Drinker
2.466200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.448010E-01
Normal-vs-Grade 2
5.402000E-03
Normal-vs-Grade 3
2.038300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.518200E-01
Grade 1-vs-Grade 3
6.138200E-01
Grade 1-vs-Grade 4
1.448010E-01
Grade 2-vs-Grade 3
6.421800E-01
Grade 2-vs-Grade 4
5.402000E-03
Grade 3-vs-Grade 4
2.038300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.999000E-01
Normal-vs-NonDiabetic
4.170000E-01
Diabetic-vs-NonDiabetic
6.032800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.573400E-01
Normal-vs-NoPancreatitis
4.161400E-01
Pancreatitis-vs-NoPancreatitis
5.890000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.448600E-01
Normal-vs-N1
3.999000E-01
N0-vs-N1
2.252800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.046400E-01
Normal-vs-TP53-NonMutant
4.338600E-01
TP53-Mutant-vs-TP53-NonMutant
4.859600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
